Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
LFSC
36
HOLDINGS
17%
ALSO IN SBIO
SBIO
75
HOLDINGS
8%
ALSO IN LFSC
SECTOR DRIFT (LFSC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in LFSC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
MIRUM PHARMACEUTICALS, INC. | 4.9% | 3.9% | 3.9% |
|
SPYRE THERAPEUTICS INC | 6.4% | 3.7% | 3.7% |
|
TRAVERE THERAPEUTICS, INC. | 7.7% | 2.8% | 2.8% |
|
DIANTHUS THERAPEUTICS INC | 3.1% | 2.6% | 2.6% |
|
PALVELLA THERAPEUTICS INC | 1.9% | 1.0% | 1.0% |
LFSC Overweight Relative to SBIO
|
COGENT BIOSCIENCES INC | 7.5% |
 |
LIVANOVA PLC | 7.1% |
|
GUARDANT HEALTH, INC. | 5.5% |
|
TRAVERE THERAPEUTICS, INC. | 4.9% |
|
CORCEPT THERAPEUTICS INC | 4.8% |
|
UNITED THERAPEUTICS CORP | 4.2% |
|
SAVARA INC | 3.2% |
|
CYTOKINETICS INC | 3.2% |
|
NEKTAR THERAPEUTICS | 3.1% |
|
TREVI THERAPEUTICS, INC. | 3.1% |
LFSC Underweight Relative to SBIO
 |
ALKERMES PLC | -4.5% |
|
KYMERA THERAPEUTICS, INC. | -4.2% |
|
CELCUITY INC. | -3.9% |
|
CG ONCOLOGY, INC. | -3.3% |
|
APOGEE THERAPEUTICS, INC. | -2.9% |
|
NEWAMSTERDAM PHARMA CO NV | -2.5% |
|
VIKING THERAPEUTICS, INC. | -2.4% |
|
CRINETICS PHARMACEUTICALS INC | -2.4% |
|
ACADIA PHARMACEUTICALS INC | -2.4% |
|
EDGEWISE THERAPEUTICS, INC. | -2.3% |